Results

Total Results: 376 records

Showing results for "renal".

201. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
     June 16, 2010 - Dynepo had been approved in Europe for the treatment of symptomatic anemia associated with chronic renal … platinum-based chemotherapy regimens may diminish endogenous erythropoietin production by damaging renal … important (or adjunctive) analysis to perform, in keeping with some of the data available from the renal

202. Measuring-Blood-Pressure Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure_executive.pdf
     January 01, 2012 - One quality C study reported on mortality and end-stage renal disease. … mortality with SMBP plus self- titration versus usual care, and lower composite mortality and end-stage renal … End-stage renal disease alone was not significantly different.

203. Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/plasma-cell-dyscrasias-sflc-assay-future_research.pdf
     September 01, 2012 - Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high … Treatment With Velcade and Dexamethasone for Previously Untreated Patients With Multiple Myeloma and Renal … Failure Due to Myeloma Cast Nephropathy Recruiting Chronic renal failure with uremic nephropathy … Multiple Myeloma (BMT CTN 0702) Recruiting MM 750 NCT00120263 Trial of Plasma Exchange for Acute Renal … Failure at the Onset of Myeloma Completed MM Acute Renal Failure 92 NCT00135187 Study of Combination

204. Colorectal-Surgery-Preparation Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-surgery-preparation_executive.pdf
     April 01, 2014 - versus enema alone or no preparation, only two provided information on harms (1 for nausea and 1 for renal … of 89 patients receiving OMBP versus 1 of 89 patients receiving no preparation experienced acute renal … Renal failure, an outcome considered important given that many OMBP strategies involve ingestion of … patients and patients with very compromised function of major systems (e.g., cardiac, pulmonary, renal

205. Treatment for Acute Pain: An Evidence Map | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/acute-pain-treatment/technical-brief

206. Frameworks for Determining Research Gaps During Systematic Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-research-steps-framework_research.pdf
     June 01, 2011 - of Nature of Reported Process Organizing Principle 1 Australia Caring for Australasians with Renal … only list the types of outcomes (e.g., maternal outcomes and fetal outcomes, liver outcomes, and renal … (NICU) admissions; liver outcomes (alanine transaminase [ALT], aspartate transaminase [AST]); and renal … Australia Medical Services Advisory Committee MSAC HTA 5 Australia Caring for Australasians with Renal … - 4 Australia Caring for Australasians with Renal Impairment CARI Yes 1999-2000 1.

207. hemangioma-protocol-141223 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_research-protocol.pdf
     December 23, 2014 - anomalies, ulceration, myelopathy, bony deformities, anorectal malformations, arterial anomalies, and renal … SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated … anomalies, ulceration, myelopathy, bony deformities, anorectal malformations, arterial anomalies, renal

208. Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
     January 15, 2015 - • Harms, risks and consequences of testing o Procedural harms, adverse events of testing (e.g., renal … Special populations and circumstances of interest include: • Patients with renal insufficiency, diabetes … Harms, risks and consequences of testing (both initial and subsequent testing) • Harms of testing (renal

209. Whole-Body Vibration Therapy for Osteoporosis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
     January 01, 2020 - can result in adverse outcomes, commonly minimal trauma atypical fractures, esophageal irritation, renal … adverse effects from bisphosphonates include minimal trauma atypical fractures, esophageal irritation, renal … smokers or past smokers within the previous 15 years; Women with current diagnosis or a history of renal … breath or chest pain Any medical condition that might affect BMD (e.g., bone cancer, end-stage renal

210. Chronic-Urinary-Retention Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
     September 01, 2014 - with lower urinary tract symptoms and CUR indicate increased risk of acute urinary retention (AUR), renal … Exclusion criteria: major hematologic, renal, or hepatic impairment and major psychiatric disorders … criteria: clinical evidence of prostate cancer, infection, previous prostatic surgery, uncontrolled renal … ml Concurrent treatment: All had a 4-6-week period of indwelling catheterization to stabilize renal … <6 months, neuropathic bladder dysfunction, serum creatinine >250 mmol, abnormal upper tracts on renal

211. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
     March 01, 2010 - What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated with the use of … The second question is, “What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated

212. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_executive.pdf
     October 01, 2007 - Outcomes according to hypertension, tobacco use, renal dysfunction, and vascular disease were not generally … Other comorbidities Weak - There was no evidence suggesting that hypertension, tobacco use, renal dysfunction

213. Heart-Failure-Transition-Care Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_executive.pdf
     May 01, 2014 - readmissions within 30 days were for HF; the remainder of readmissions were for diverse indications (e.g., renal … that 35 percent of 30-day readmissions are for HF; the remainder are for diverse indications (e.g., renal … Included trials commonly excluded patients who had end-stage renal disease or severe or unstable cardiovascular

214. Horizon Scanning_Rapid Cost Analyses of Selected Potential High-Impact Intervention Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
     January 01, 2015 - Depending on the success of the development pathway for some of the interventions, such as catheter-based renal … Lymphomas Intranasal Oxytocin for Social Dysfunction in Autism Spectrum Disorders Catheter-Based Renal … Catheter-Based Renal Denervation (Symplicity System) for Treatment- Resistant Hypertension The Symplicity … Assuming a 50% decrease in the need for antihypertensive medications after catheter-based renal denervation … Cell Carcinoma Pharmaceutical $180,000,000 $140,000,000 Cardiovascular Disease Catheter-Based Renal

215. Disposition of Comments_Technical Brief No. 40: Interventions To Decrease Hospital Length of Stay (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hospital-length-of-stay-disposition-comments_0.pdf
     September 20, 2021 - review is that it primarily focuses on medical (non-surgical) conditions, such as diabetes, COPD, renal

216. Vitamin D and Calcium: A Systematic Review of Health Outcomes (Update) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
     September 01, 2014 - body weight outcomes, cancer, immune function, pregnancy or birth outcomes, mortality, fracture, renal … levels, such as all-cause mortality, cancer (incidence and mortality), soft tissue calcification, renal … Renal Outcomes As described in the original report, the WHI trial (vitamin D3 400 IU in combination … with 1,000 mg calcium carbonate vs. placebo) found an increase in the risk of renal stones. … diarrhea, or upset stomach), musculoskeletal soreness, primary hyperparathyroidism, hypercalcemia, and renal

217. Hypertension-Drugs-Utilization Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
     January 25, 2011 - Freeman, M.P.H.2,3 1 Renal Electrolyte and Hypertension Division, University of Pennsylvania School

218. Meeting Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
     January 01, 2011 - Collyar President, Patient Advocates in Research (PAIR) Virna Elly Patient Advocate, Mid-Atlantic Renal

219. Pneumonia-Antibiotic-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
     November 01, 2014 - , or antibiotic- related adverse events differ for subgroups defined by age, sex, race, ethnicity, renal … pharmacokinetic variability based on patient-specific factors such as critical illness, body weight, renal

220. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hepatitis-c-treatment-adherence_research-protocol.pdf
     September 13, 2011 - population includes patients for whom treatment is contraindicated:  Pregnant women  Patients with renal … population include patients for whom treatment is contraindicated:  Pregnant women  Patients with renal